HAMP and Hepatic fibrosis: Calcium channel blockers (CCBs), on the other hand, reduce iron-load in liver and reverse hepatic fibrosis by mechanisms that include lowering of ferritin and DMT1 levels, but there are no studies that have examined if CCBs affect hepcidin mode of production or action (Zhang et al. 2016).